Inovatyvi medicina - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 0 | 24,000 | 100,440 | 75,000 | 216,515 | 75,000 | - | - |
| Profit before tax | -12,175 | -21,562 | 44,435 | -11,319 | -110,545 | -154,973 | -1,708,895 | -2,937,381 |
| Net profit | -12,175 | -21,562 | 44,435 | -11,319 | -110,545 | -154,973 | -1,708,895 | -1,248,359 |
| Equity | 37,850 | 16,288 | 60,724 | 49,405 | 157,104 | 6,002,131 | 4,293,236 | 3,044,877 |
| Liabilities | 21,628 | 27,883 | 100,828 | 243,744 | 171,879 | 139,228 | 202,916 | 5,636,467 |
| Non-current assets | 17,069 | 11,844 | 55,151 | 41,627 | 159,950 | 693,741 | 2,019,125 | 3,726,467 |
| Current assets | 42,409 | 45,035 | 106,401 | 271,522 | 747,580 | 5,528,595 | 2,490,754 | 4,923,976 |
| Total assets | 59,478 | 56,879 | 161,552 | 313,149 | 907,530 | 6,222,336 | 4,509,879 | 8,650,443 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 87,158 | 39,021 | 148,045 |
| Social insurance contributions | - | - | - | - | - | 192,028 | 335,924 | 361,625 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +318.5% | -25.3% | +188.7% | -65.4% | - | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -20.5% | -37.9% | 27.5% | -3.6% | -12.2% | -2.5% | -37.9% | -14.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -32.2% | -132.4% | 73.2% | -22.9% | -70.4% | -2.6% | -39.8% | -41.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -89.8% | 44.2% | -15.1% | -51.1% | -206.6% | - | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -89.8% | 44.2% | -15.1% | -51.1% | -206.6% | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.6 | 1.7 | 1.7 | 4.9 | 1.1 | 0.0 | 0.0 | 1.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 3,310 | 14,521 | 6,716 | 13,747 | 3,358 | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Inovatyvi medicina - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-06-16 | 2026-07-08 | 0.05 |
| 2026-05-17 | 2026-06-04 | 0.05 |
| 2026-02-18 | 2026-03-05 | 11.82 |
| 2023-12-18 | 2023-12-27 | 0.23 |
| 2023-11-16 | 2023-12-10 | 0.23 |
| 2022-05-17 | 2022-05-19 | 5.77 |
| 2022-04-25 | 2022-05-03 | 5.77 |
| 2022-04-19 | 2022-04-24 | 0.18 |
| 2022-03-16 | 2022-04-06 | 0.18 |
| 2022-02-18 | 2022-03-09 | 0.18 |
| 2022-02-17 | 2022-02-17 | 6214.29 |
| 2022-01-28 | 2022-02-16 | 0.18 |
| 2021-12-16 | 2021-12-26 | 18.03 |
| 2021-11-16 | 2021-12-06 | 18.03 |
Inovatyvi medicina - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-19 | 2025-06-26 | 0.12 |
| 2025-06-14 | 2025-06-18 | 26.78 |
| 2025-02-20 | 2025-02-25 | 197.78 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.